Dr. Rajesh Ponugupati. 2016. “EFFICACY AND SAFETY OF DUAL INTERLEUKIN-17A AND INTERLEUKIN-17F INHIBITION WITH BIMEKIZUMAB IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 RANDOMISED CONTROLLED TRIAL”. Journal of Population Therapeutics and Clinical Pharmacology 23 (2): 237-46. https://doi.org/10.53555/am143177.